The nifF gene of Klebsiella pneumoniae was cloned into a multicopy plasmid in order to construct a strain that synthesizes and retains an elevated concentration of the gene product relative to the wild-type strain. Characterization of the isolated flavodoxin, which serves as an electron donor to nitrogenase, shows unambiguously that it is the product of the nifF gene.
INTRODUCTION
The nitrogen-fixation (nij) gene cluster of Klebsiella pneumoniae comprises 17 genes that are required for the synthesis and activity of nitrogenase in vivo . K. pneumoniae nitrogenase comprises the MoFe protein (Kpl; Mr 220000, 32Fe and 2Mo atoms/molecule) and the Fe protein (Kp2; Mr 67000, 4Fe atoms/molecule). Kpl is a tetramer of two non-identical subunits (a and ,; Mr 56000 and 60000 respectively), which are the products of nifD (a) and nifK (,f). Kp2 is a dimer composed of two identical subunits specified by nifH. The nifHDK genes are contiguous and are transcribed from a promoter adjacent to nifH. The products from the nine genes nifQ, nifB, nifA, nifL, nifM, niJV, nifS, nifN and nifE are involved in post-translational processing (including the assembly of Fe-S and Fe-Mo-S centres) of the nifHDK-gene-product peptides or in the regulation of their synthesis and activity in response to, for example, NH4+ and 02 concentrations Hill et al., 1981) . The function of the nVX, nifY and nifU gene products is not known. The 17 nif genes are arranged in seven operons, the expression of which is activated by the nifA gene product in concert with the ntrA gene product (Drummond et al., 1983 , and references cited therein).
In the present context, the apparent high affinity of the nifH promoter relative to that of the nifF promoter for these activators is of particular relevance (Buchanan-Wollaston et al., 1981a; Reidel et al., 1983; Brown & Ausubel, 1984) .
A flavodoxin, purported to be the nifF gene product, mediates electron transfer from the nifJ gene product, a pyruvate: flavodoxin oxidoreductase, to the Fe protein of nitrogenase (Kp2) (Scheme 1) (Hill & Kavanagh, 1980; Nieva-Gomez et al., 1980; Shah et al., 1983) . Yates (1972) showed that the fully reduced, hydroquinone, state of a flavodoxin isolated from Azotobacter chroococcum effected a single electron transfer to the Fe protein of A. chroococcum nitrogenase protein, the semiquinone state of the flavodoxin being a product of this reaction. Shah et al. (1983) also concluded that the hydroquinonesemiquinone states of Kp flavodoxin were operating in the electron-transport pathway shown in Scheme 1, in which pyruvate is the source of reducing equivalents.
In vitro, Na2S204 will substitute for flavodoxins as an electron donor to nitrogenase (Bulen et al., 1965) . It has been used frequently in both equilibrium and kinetic studies because of its low potential, ready availability and comparative stability in solution at neutral pH. The component proteins of nitrogenase are usually prepared in the presence of approx. 1 mM-Na2S204 under an atmosphere of N2 or Ar with the use of a variety of techniques for minimizing damage by adventitious 02 . The availability of glove-boxes filled with high-purity N2 (less than 1 p.p.m. 02) enables S2042ions to be removed from solutions of Kp 1 and Kp2 without loss of activity (Thorneley & Lowe, 1983) . The installation of a stopped-flow spectrophotometer in an anaerobic glove-box made possible a kinetic study of the reduction of Kp20. (MgADP)2 by S02-(formed by the predissociation of S2042-= 2SO2 -) and the modulation of this reaction by complex-formation with Kpl (Thorneley & Lowe, 1983) . It is now therefore technically feasible and desirable to study the kinetics and mechanism of electron-transfer reactions between Kp flavodoxin (the natural electron donor) and Kp2 protein. A source of purified flavodoxin in quantities of about 10-20mg is required for a detailed characterization, redox-potential determination and kinetic investigation by stopped-flow spectrophotometry.
Previous attempts in this laboratory to isolate a 
.5-,0 ,0 _-00 "D Electron transfer to nitrogenase in Klebsiella pneumoniae flavodoxin from K. pneumoniae M5al (a wild-type Nifp strain) failed (Hill & Kavanagh, 1980) . Although Nieva-Gomez et al. (1980) and Yoch (1974) succeeded in isolating and partially characterizing Kp flavodoxin, no yields were reported, and from the nature of their experiments with purified material a low yield can be inferred. In addition, Nieva-Gomez et al. (1980) and Shah et al. (1983) provided no evidence that the flavodoxin that they isolated was the product of the nifF gene.
We therefore decided to clone the nifF gene into a multicopy plasmid and construct a strain of K. pneumoniae that would synthesize and retain an elevated concentration of active flavodoxin relative to strain M5al. In the present paper we describe the procedure adopted and a characterization of the flavodoxin obtained that unambiguously shows it to be the product of the nifF gene.
MATERIALS AND METHODS Bacterial strains and plasmids
The strains of Klebsiella pneumoniae are listed in Table 1 .
Media
Strains were grown in Nutrient Broth (NB), Luria Broth (LB) or Nitrogen-Free Davis and Mingioli Medium (NFDM) as described by Dixon et al. (1977) . These media were supplemented, when required, with filter-sterilized stock solutions to give final concentrations of: carbenicillin, 200 ,ug/ml; chloramphenicol, 20 or 40 ,g/ml; kanamycin, 25 ,g/ml; ampicillin, 200 ,g/ml; L-histidine, 30 or 50 ,ug/ml; (NH4)2SO4, 200 or 1000 ,ug/ml. All biochemicals were purchased from Sigma Chemical Co., Kingston-upon-Thames, Surrey, U.K., and salts from BDH Chemicals, Poole, Dorset, U.K.
Cloning procedures
Details of methods used for DNA restriction and ligation during cloning have been described by Cannon (1980) and Maniatis et al. (1982) . Restriction enzymes were purchased from Boehringer Mannheim and used according to the manufacturer's instructions.
Plasmid purification
Plasmids were purified by the boiling method of Holmes & Quigley (1980) and also by poly(ethylene glycol) precipitation with subsequent CsCl-densitygradient centrifugation at 232000 g for 40-60 h at 4°C in a Pegasus 65 ultracentrifuge (MSE, Crawley, Sussex, U.K.) fitted with an 8 x 35 ml angle rotor (Humphrey et al., 1975) . Transformation K. pneumoniae strains UNF696 and UNF926 were transformed by the method of Cohen et al. (1972) with the following modifications. Cells (100 ml with approx. 2 x 108 organisms/ml), which had been treated with 50 mM-CaCl2, were incubated with 400 ng of DNA at 0°C for 1-2 h. A heat shock was carried out for 3 min at 32°C for UNF696 and for 3 min at 42°C for UNF926. The cells of UNF696 and UNF926 were suspended in Luria Broth (5 ml) and grown for 3 h at 30°C or 37°C respectively. A series of dilutions were plated on to selective plates and incubated at the appropriate temperature. Agarose-gel electrophoresis Digested DNA was fractionated by electrophoresis in horizontal 0.8 and 1.0% agarose gels in TAE buffer (40 mM-Tris/5 mM-sodium acetate/I mM-disodium EDTA, adjusted to pH 7.8 with acetic acid) for 16 h with a current of 40 mA as described by Cannon (1980) . The gels were stained and photographed by the procedure described by Cannon et al. (1977) . " C-pulse-abelling This was performed essentially by the procedure of Cannon (1980) , except that 200 ml cultures were labelled for 10 min with 10 #1 of 14C-labelled amino acid mixture (50 ,uCi/ml) in screw-capped Eppendorf tubes (2 ml volume). Labelled samples were then subjected to polyacrylamide-gel electrophoresis as described below. Polyacrylamide-gel electrophoresis A modified Ortec gel system was used as described by Cannon (1980) , with a 13% or 15% separating gel and a 5% stacking gel. The steady-state intracellular concentration of soluble protein was determined from Coomassie-Blue-R-250-stained polyacrylamide gels of denatured cell protein by using a Unicam SP. 1800 spectrophotometer fitted with a scanning densitometer accessory. After electrophoresis of 14C-pulse-labelled samples, the gels were dried under vacuum and exposed to X-ray film (Fuji RX) for 7-14 days.
Growth of strains
Strains UNF3001, UNF1202 and UNF1624 were grown as described by Hill & Kavanagh (1980) . Strain UNF926 was grown as follows: a 6 h aerobically grown culture in LB (50 ml) was used as an inoculum for 500 ml ofNFDM containing (NH4)2SO4 (1 mg/ml) and histidine (50 ,tg/ml). After 16 h at 30°C, with sparging with N2, the cells were harvested by centrifugation at 31 770 g for 5 min at 4 'C. The supernatant was discarded, and the cells were resuspended in 500 ml of NFDM containing histidine (50 ,ug/ml), and de-repressed by sparging with N2 for a further 4 h at 30 'C. Organisms were harvested by centrifugation as described above.
Strain UNF5112 cells in 0.5-litre, 1.5-litre and 3.0-litre cultures were grown as for strain UNF926 but with carbenicillin(200 jug/ml)andchloramphenicol (20 ,ug/ml) in both LB inoculum and NFDM containing (NH4)2SO4 (1 mg/ml) and histidine (50 ,ug/ml). The 20-litre and 400-litre cultures were grown as follows. An N2-sparged culture in 500 ml of LB containing carbenicillin (200 ,ug/ml) and chloramphenicol (20 ,tg/ml) was inoculated into 20 litres of NFDM containing histidine (50 ,ug/ml), chloramphenicol (20 ,ug/ml), carbenicillin (200 jug/ml) and (NH4)2SO4 (200 ,ug/ml). Cells were grown for 16 h at 30 'C under N2 and then used as an inoculum for 400 litres of NFDM supplemented with histidine (50 gcg/ml) and (NH4)2SO4 (200 ,ug/ml) . After 13 h at 30 'C, cells were harvested by using a Westfalia SA7 continuous centrifuge.
Preparation of cell-free extracts
A 5000 (w/v) suspension of cells in 25 mM-Tris/HCI buffer, pH 7.4, was disrupted by passage through a French pressure cell as described by Eady et al. (1972) and
Vol. 231 745 centrifuged at 49640 g for 1 h at 4 'C. Protein concentration was measured by the procedure of Lowry et al. (1951) , with bovine serum albumin (Sigma Chemical-Co.) as standard. Acetylene-reduction assays Whole-cell assays. A 0.1 ml portion of a 16 h aerobically grown culture in NB was added to 4 ml of NFDM containing histidine (30 ,g/ml) in 7 ml plastic vials and capped with Suba-Seal rubber closures. The cultures were incubated at 30 'C on a rotary shaker for 5-16 h. Acetylene (1 ml) was injected above the cultures, which were then shaken for a further 30 min. Ethylene production was measured in 0.5 ml gas samples by vapour-phase chromatography as described by Cannon et al. (1977) .
Assay for the nifp gene product. These assays were carried out by the method described by Hill & Kavanagh (1980) , with 26 mM-sodium pyruvate as the source of reducing equivalent. Crude extracts of strains UNF5112 and UNF926 (0.4 mg per assay) were assayed for activity by reconstituting the electron flow to nitrogenase in crude extracts of either an nifF mutant (UNF1202 or UNF1624) or wild-type strain UNF3001 (0.66 mg per assay). Ethylene production was assayed as described above.
Isolation of the nifF gene product
The nifF gene product from strain UNF5112 was isolated by using a combination of the methods described by Nieva-Gomez et al. (1980) and Shah et al. (1983) . A crude extract of strain UNF5112 was prepared as described above. The pellet of broken cells, obtained after removal of the supernatant crude extract, was suspended in 200 mM-potassium phosphate buffer, pH 7.4 (1 g ofcell pellet per 2 ml of buffer). Triton X-100 was added to 1 % (v/v) and the suspension stored at -20 'C overnight. The suspension was thawed, diluted 6-fold with distilled water and centrifuged at 31770 g for 40 min at 4 'C. The supernatant solution was combined with the crude extract and treated as described below. All operations were at 5 'C in air.
The crude extract supernatant mixture was applied to a DEAE-cellulose column (5 cm x 10 cm) that had been equilibrated with 25 mM-Tris/HCl buffer, pH 7.4. The column was washed with 100 ml of the same buffer and developed by successive 100 ml washes with buffer containing 100 mM-, 150 mm-, 200 mm-and 350 mM-NaCl. Fractions were assayed for flavodoxin activity by reconstituting electron flow to nitrogenase in an extract of an nifF mutant as described above. The flavodoxin was eluted in the 350 mM-NaCl fractions. The active fractions were combined, diluted with an equal volume of buffer and applied to a second DEAE-cellulose column (3 cm x 12 cm), which had been equilibrated with buffer containing 200 mM-NaCl. The flavodoxin was then eluted with buffer containing 350 mM-NaCl. The fractions containing-active flavodoxin were pooled, diluted 3-fold with buffer and concentrated by absorption on DEAEcellulose followed by elution with buffer containing 350 mm-NaCl. The concentrated flavodoxin was then applied to a Sephadex G-50 column (2.5 cm x 50 cm) equilibrated with 25 mM-Tris/HCl buffer, pH 7.4, and the column was eluted at a flow rate of 10 ml/h. The most active fractions were pooled and concentrated on DE-AE-cellulose as described above. The flavodoxin was subsequently purified . to homogeneity by using a preparative gel-electrophoresis apparatus as described by Ludden et al. (1978) . The gel was loaded with a solution of flavodoxin (4 ml; approx. 5 mg/ml) containing 10% (w/v) sucrose and electrophoresed through the stacking gel for 16 h at 40 V, 150 pulses/s. Electrophoresis was continued at 160 V, 150 pulses/s, until fractions had been collected.by elution across the bottom of the running gel in 100 mM-Tris/acetate buffer pH 8.0. Fractions were concentrated on DEAE-cellulose as described above. The purity of the flavodoxin was ascertained after each purification step by analytical SDS/polyacrylamide-gel electrophoresis (Cannon, 1980) .
Amino acid-composition
Purified flavodoxin (100 ,sg) was hydrolysed in 1 ml of 6 M-HC1 at 110°C for 24 h in an evacuated sealed 8 mm x 100 mm rimless Pyrex test tube. The tube was then opened and the contents were dried in a vacuum desiccator containing NaOH pellets. The hydrolysed sample was then redissolved in 1 mM-HCl and the amino acid composition was determined by using a Locarte amino: acid analyser.
N-Terminal aminoacid analysis
The N-terminal amino acid residue was determined with dansyl chloride (5-dimethylaminonaphthalene-1sulphonyl chloride) by using a modified version of the method described by Allen (1981 a,b) . Purified flavodoxin (100 jug) was precipitated with ice-cold 500 (w/v) trichloroacetic acid. The precipitated protein was resuspended in 50,1 of 0.1 M-NaHCO3 in a borosilicate glass tube (5 mm x 50 mm), and an equal volume of dansyl chloride (5 mg/ml) in acetone was added. After gentle mixing the reaction mixture was left at 23°C for 4-5 h and then evaporated to dryness in a vacuum desiccator containing NaOH pellets. After addition of 6 M-HCI (0.1 ml), the tubes were sealed and kept at 110°C for 5 h. After cooling to room, temperature, the tube was opened, the contents were dried in vacuo and the N-terminal dansylated amino acid residue was extracted with water-saturated ethyl acetate. The N-terminal amino. acid residue was determined by two-dimensional t.l.c. on double-sided 5 cm x 5 cm polyamide layer plates with the. mixed solvent systems described by Woods & Wang (1967) .
C-Terminal amino acid analysis
The C-terminal amino acid determination was based on a procedure described by Allen (1981a) . Carboxypeptidase A was suspended in water and centrifuged. The supernatant, which contains contaminating amino acids, was discarded. The pellet was then dissolved in a minimum volume (approx. 50,l) of 2 M-NH4HCO3, added to the 400,ug offlavodoxin (220 nmol) in 0.5-1.0 ml Plasmids pBCC12 and pBCCl3 were constructed from pPMl1, a plasmid derived by inserting the fragment RI(n#fJ) to HindIII(nifK) ofpSA3O into pBR328. For plasmid pBCC12 a Bg1II(nigL)-BamHI(nifM) fragment from pMC9 was inserted into pPM 1, and for plasmid pBCC13 the fragment Bg11I(niJL)-Xho/SalI1M) from pMC9 was inserted into pPM1. Plasmids were wlected by size afkr colony screening on agarose gds, and the orientation of the inserted fragment was determined by mapping restriction..enzyme sites Cm, Amp and Tc refer to chloramphenicol-resistance, ampicillin-resistance and tetracycline-resistance genes; J, H, D, K. F, M andL refer to the corresponding nifgenes, -and RI, BglII, HindIII, -BamHI and Sall refer to restriction sites. 
Fig. 2. Restriction map of plasmids pBCC13 and pBCC12
This restriction and genetic map shows the nif genes that are present on plasmids pBCC13 and pBCC12. The restriction sites shown are those that are important for the construction of the niJFclones, plasmids pBCC 13 and pBCC 12 and for the assignment of the orientation of the nifF-nifL-nifM fragment in these plasmids. Abbreviations: Cm, chloramphenicol; Tc, tetracycline; Amp, ampicillin. These values were obtained from three independent experiments. Each assay was carried out in duplicate. Acetylene reduction (%O) is defined as the nmol of ethylene produced given as a percentage of the Kp5022 (wild-type) value. A 5 h-de-repressed culture of K. pneumoniae 5022, with A540 0.06, gave 10.4 nmol of ethylene/0.5 ml of gas sample, and the 16 h-de-repressed culture, with A540 = 0.12, gave 22.6 nmol of ethylene/0.5 ml of gas sample. (A540 values were measured with an EEL spectrophotometer.) These values were used to normalize the data obtained for the different strains at the two de-repression times. 
Acetylene reduction Acetylene reduction

RESULTS AND DISCUSSION
Cloning the nipF gene Two plasmids that both carry a nifL-nifF-nifM fragment, but cloned in different orientations, have been constructed (Fig. 1) . Plasmid pBCC12 carries a BglII (nifL)-(nifM) fragment, and plasmid pBCC13 carries a Bg1I(nifL)-Sa1I(nifM) fragment. These fragments have been individually cloned into pPMI, a plasmid derived by inserting an EcoRI/HindIII fragment carrying nifJ-nifH-nifD-nifKinto plasmid pBR328. The different orientations of the nifL-nifF-nifM fragment in plasmids pBCC12 and pBCC 13 were determined by restriction mapping (Fig. 2) . When these plasmids were originally constructed the direction of transcription of the nifF gene was uncertain.
In an attempt to maximize expression of the nifF gene, plasmids pBCC1 2 and pBCC 13 were constructed with the strong nifH promoter upstream from nifF. Studies by Beynon et al. (1983) and Drummond (1985) have shown that nifF is transcribed in the opposite direction to nifL (Fig. 2) . It is therefore not surprising that strain UNF5112 carrying pBCC1 3 gave an 8-fold higher yield of the nifF gene product than did wild-type strain UNF3001 (see below). However, it is difficult to estimate the precise advantage of using a construct with a nifH promoter, for two reasons. Firstly, all the promoters associated with nif genes in Fig. 2 Reidel et al., 1983) . This may prevent the initiation of transcription of the nifF gene from its own promoter. This multicopy effect is discussed below, where a comparison of nifF gene expression from the two plasmids is made. Secondly, it is possible that nifL transcription from the opposite end of nifH in pBCC13 (as shown in Fig. 2 ) prevents significant read-through from nifH into nifF. Also the intergenic region between nifL and nifF might contain sequences that modulate enhanced transcription of nifF initiated from the nifH promoter.
Expression of the cloned niJF gene
The two plasmids pBCC12 and pBCC13 were transformed into strain UNF696, which carries a nifF point mutation, to give strains UNF2361 = UNF696 (pBCC12) and UNF2362 = UNF696 (pBCC13). No significant genetic complementation was detected (Table  2) . A possible explanation is that the multiple copies of of'4C-labelled amino acids as described by Cannon (1980) . The 14C-pulse-labelled samples were then subjected to SDS/polyacrylamide-gel electrophoresis, with 15 000 c.p.m. being loaded for each sample. All subsequent procedures are described in the Materials and methods section. Lane 1, Mr markers, 30000, 18 000 and 12 500; lane 2, strain UNF926 (hisA nifA); lane 3, strain UNF51 12 = UNF926 (pMC71A, pBCC 13); lane 4, strain UNF2372 = UNF926 (pBCC13). the nifH promoter present in these strains titrate out all the nifA gene product (see the preceding subsection).
Strains UNF2363 and UNF2364 were therefore constructed carrying the nifA constitutive plasmid pMC71A in addition to plasmids pBCC12 and pBCC13. These strains did not show any enhanced acetylene-reduction activity ( Table 2) . We were thus unable to obtain genetic evidence for a copy number effect. However, decreased concentrations of nifJ-, nifH-, nifDand niJK-geneproduct polypeptides were observed even when the nifA constitutive plasmid was present (Fig. 3) . The rate of acetylene reduction is a function of the concentration of these peptides as well as that of the nifF-gene-product peptide. We conclude that whole-cell acetylene-reduction activity is not related in a simple manner to the Table 3 . Assays for the niJF gene product, measured by acetylene-reducing activity in crude extracts of wild-type and mutant strains Crude extracts of UNF5112 and UNF926 (0.66 mg of protein per assay) were assayed for acetylene-reducing activity by reconstituting electron flow to nitrogenase in crude extracts (0.66 mg of protein per assay) of either a nifFmutant (UNF1202 or UNF 1624) or wild-type strain (UNF3001). The assays were performed at 30°C for 10 min. Figure) . The purified protein has Mr 19000, which, from scanning densitometry of strain UNF5112, is present as 3-4% of total soluble protein inside the cell.
concentration of the nifF-gene-product peptide and that acetylene-reduction data cannot be used to estimate the relative concentrations of the nifF-gene-product peptide in the relevant strains in Table 2 . However, plasmids pBCC13 and pBCC12 do complement strain UNF696 for growth on nitrogen-free solid media, indicating that a functional niWF gene is present on these plasmids. Fig. 3 shows two heavily labelled polypeptides in strains carrying plasmid pBCC13 (e.g. UNF2362), with Mr values of 19000 and 22000, that were absent from strains with plasmid pBCC12 (e.g. UNF2361). Kp flavodoxin has an Mr close to 20000 (Yoch, 1974; Nieva-Gomez et al., 1980) . We confirmed that these products were nif-specific by showing that their formation was augmented by nifA gene product (from plasmid pMC71A) in an nif-deletion background (Fig. 4 ).
Therefore plasmid pBCC13 was chosen in preference to plasmid pBCC12 for further characterization of the presumptive nifF gene product.
Assay of the presumptive niJF gene product
The presumptive nifF gene product was assayed for activity by biochemical complementation of pyruvatesupported nitrogenase activity (Hill & Kavanagh, 1980; Nieva-Gomez et al., 1980) . Table 3 shows that crude extracts of strain UNF5112 stimulated pyruvate-supported acetylene reduction about 100-fold in extracts of two nifF-strains (UNF1202 and UNF1624) and augmented activity about 10-fold in extracts of the wild-type strain (UNF3001). This latter observation is consistent with the report by Hill & Kavanagh (1980) that pyruvatesupported acetylene-reduction activity with crude extracts of K. pneumoniae (M5al) is limited by the concentration of the nifF gene product. The crude extract of strain UNF5112 also enhanced the activity of a crude extract of strain UNF3001 in the presence of S2042-. The The spectrum recording was made with 33 4tM-flavodoxin in 25 mM-Hepes buffer, pH 7.4, in a 1 cm-pathlength cell.
of purified Azotobacter vinelandii flavodoxin to stimulate dithionite-supported acetylene reduction by purified A. vinelandii nitrogenase under certain conditions of component protein ratio has been reported by Hageman & Burris (1978) and explained by Thorneley & Lowe (1984) . Yield of the purified nilF gene product from strain
UNF5112
The nifF gene product was purified as described in the Materials and methods section, monitored by the assay system described above. A single band corresponding to Mr 19000 after SDS/polyacrylamide-gel electrophoresis (Fig. 5 ) and a u.v.-visible-absorption spectrum for the oxidized protein with an absorption coefficient at 454 nm of 10.0 + 0.5 mm-' cm-' were used as criteria for peptide homogeneity and FMN content (Fig. 6) . Table 4 shows that with soluble and membrane-bound cell protein from 100 g (wet wt.) of cells of strain UNF5112 (1.04 g of total protein), 12 mg of purified flavodoxin was obtained, corresponding to a 390% recovery of activity units. This recovery is more than twice that reported by Nieva-Gomez et al. (1980) for their purification of Kp flavodoxin from wild-type K. pneumoniae (M5al). We have not attempted a purification of Kp flavodoxin from K. pneumoniae (M5al) in order to compare the absolute yields of purified flavodoxin with that from strain UNF5112. However, a comparison ofCoomassie-Blue-R-250-stained SDS/polyacrylamide gels of wild-type strain UNF3001 and strain UNF5112 by scanning densitometry showed that Kp flavodoxin (Mr 19000) was present in UNF5112 at concentrations corresponding to 3-4%o of the total soluble protein. The corresponding value for strain UNF3001 was only 0.5%.
Comparison of the M, and amino acid composition of Kp flavodoxin from strain UNF5112 with that predicted from the nipF gene sequence
The Mr of the Kp flavodoxin purified from strain UNF5112 was determined by SDS/polyacrylamide-gel electrophoresis to be 19000+500. This is in agreement with a value of Mr 18950 determined from the DNA sequence for nifF gene (Drummond, 1985) and previous values of Mr approx. 20000 (Yoch, 1974; Nieva-Gomez et al., 1980) . Table 5 shows a comparison ofamino acid composition data determined for Kp flavodoxin from strain UNF5112 by using conventional amino acid analysis after protein hydrolysis (see the Materials and methods section) with that calculated from the DNA sequence data for the nifF gene obtained by Drummond (1985) . The agreement between the two data sets is within the estimate of experimental error (±500) inherent in the amino acid analysis procedure employed with the protein.
The N-terminal amino acid residue of Kp flavodoxin was determined to be alanine. The sequence at the C-terminus was shown to be Leu-Val-Thr-Arg. These findings are in precise agreement with DNA sequence data for the nifF gene (Drummond, 1985) .
These data show unequivocally that the flavodoxin purified from UNF5112 is the product of the nifF gene. The co-migration of the purified flavodoxin from strain UNF5112 with the 19 000-Mr polypeptide synthesized in the 14C-labelling experiment with strain UNF5112 (Fig.  7) allows the assignment of this polypeptide as the nifF gene product. The 22000-Mr polypeptide, which could have been mistaken for the niJF gene product, is probably a nifH-nifL-gene-product hybrid protein that is transcribed from the nifH promoter. The crude extract mixture assayed included the soluble and membrane-bound protein obtained from 100 g (wet wt.) of UNF5112. The nifF gene product was assayed at each stage of purification by reconstituting electron flow to nitrogenase in a crude extract of the nifF mutant UNF 1202 (0.66 mg per assay). Assays were carried out at 30°C over 10 min. The maximum specific activity obtained with a range of protein concentrations (24-660 ,ug per assay) is given at each stage of purification. Table 5 . Amino acid composition analysis of nifF gene product Two independent determinations were made on the purified 19000-Mr protein from strain UNF5112. These data (column 1) are compared with the amino acid composition of the niJFgene product (column 2) calculated from the gene sequence determined by Drummond (1985) . Abbreviation: N.D., not determined. Total 174 The purified 19000-Mr polypeptide was mixed with a "4C-pulse-labelled extract of strain UNF5112 and subjected to SDS/polyacrylamide-gel electrophoresis. After Coomassie-Blue-R-250 staining the gel was dried and exposed to X-ray film as described in the Materials and methods section. Lane 1, Mr markers (values shown on Figure) ; lane 2, purified 19000-Mr protein; lane 3, purified
Specific activity
The successful cloning of the nifF gene and purification of the gene product, Kp flavodoxin, in yields about 8-fold greater than those obtained from wild-type strains will greatly facilitate the detailed characterization of this flavodoxin. It will also enable the electron-transfer system to nitrogenase to be investigated by using spectroscopic, electrochemical and kinetic techniques that require relatively high concentrations of protein.
